A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.
A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research effort has uncovered how a highly aggressive type of pancreatic cancer is ...
News-Medical.Net on MSN
Reframing the role of MCL1 in cancer signaling and metabolism
A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...
Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...
Clinical Trials Arena on MSN
Immuneering progresses MAPK inhibitor in lung and pancreatic cancer
The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...
A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...
3don MSN
Some mammals can hit pause on a pregnancy—understanding how that happens could help us treat cancer
Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results